3 Undervalued Stocks to Buy as Optimism Persists Despite Rate-Cut Uncertainty
Investing.com | Mar 14, 2024 21:45
- While markets have taken a breather, we remain in a bull market.
- Despite recent data not being favorable, we are yet to see a deep correction.
- In this scenario, we will discuss three stocks that have lagged the broader market slightly and could catch up soon.
- In 2024, invest like the big funds from the comfort of your home with our AI-powered ProPicks stock selection tool.
Since the start of the year, the S&P 500 has hit new record highs, gaining 8.3% in the process.
Despite recent data showing slightly worse-than-expected inflation and unemployment rates, there hasn't been a correction yet, indicating that buyers are in control.
Given this scenario, one interesting strategy is to look for undervalued companies with bullish potential as market optimism persists.
In this regard, three stocks stand out, and in this piece, we will discuss them individually.
h2 1. Chevron/h2Chevron (NYSE:CVX) experienced sharp declines last October following news that it had acquired Hess (NYSE:HES). However, it has been gradually recovering since the beginning of the year, gaining over 3%.
With the stock still about $36 below its historical highs, there's room for further gains. The fair value index suggests a potential move of more than 23%, indicating bullish prospects.
Source: InvestingPro
It's important to highlight that Waren Buffett's Berkshire Hathaway (NYSE:BRKb), has boosted its investment in the company.
As per the latest f13 report, which mandates large investment funds to disclose current holdings, Berkshire Hathaway has purchased 16 million shares, raising its stake in the portfolio to 5.3%. This move positions it as the fifth largest holding.
The company maintains strong growth fundamentals and the potential to enhance free cash flow, allowing for successive sharing of growing profits with shareholders.
h2 2. STMicroelectronics/h2STMicroelectronics (NYSE:STM), a French-Italian company, makes electronic circuits. In recent years, these circuits have become crucial in the global semiconductor landscape.
Get The App
Despite entering a consolidation phase, the company's stock price remains in an overall uptrend.
The demand side needs to surpass the recent peak price of $51 per share. Breaking through this level will pave the way for challenging the all-time high prices.
Fundamentally, it's crucial to note the strong cash flow. It comfortably covers the debt, with cash fully covering the current debt.
Source: InvestingPro
h2 3. Haemonetics (NYSE:HAE) Corporation/h2Haemonetics Corporation, a prominent player in the medical industry, specializes in providing blood and plasma services.
Following a challenging period during the pandemic, the company experienced a sales recovery in 2023, with forecasts indicating continued growth in the current year, ranging from 4% to 7%.
A significant recent development announced earlier this month was the acquisition of Chicago-based Attune Medical for $160 million. This acquisition is expected to drive earnings growth in the years to come.
Recently, the company's stock price has seen a rebound, supported by strong defense near $72 per share. Currently, it is trading in the range of $72 to $80 per share.
The breakout of the upper limit of the aforementioned range remains crucial and could potentially pave the path toward $90 area.
***
Take your investing game to the next level in 2024 with ProPicks
Institutions and billionaire investors worldwide are already well ahead of the game when it comes to AI-powered investing, extensively using, customizing, and developing it to bulk up their returns and minimize losses.
Now, InvestingPro users can do just the same from the comfort of their own homes with our new flagship AI-powered stock-picking tool: ProPicks.
With our six strategies, including the flagship "Tech Titans," which outperformed the market by a lofty 1,183% over the last decade, investors have the best selection of stocks in the market at the tip of their fingers every month.
For readers of this article, now with the code: INWESTUJPRO1 as much as 10% discount on annual and two-year Invest ingPro subscriptions.
Do you only use the Investing app? This offer is also for you! InvestingPro for the app now also 10% off with INWESTUJPRO1. Enter discount code TU.
Disclaimer: This article is written for informational purposes only; it does not constitute a solicitation, offer, advice, or recommendation to invest as such it is not intended to incentivize the purchase of assets in any way. I would like to remind you that any type of asset, is evaluated from multiple points of view and is highly risky and therefore, any investment decision and the associated risk remains with the investor.
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.